| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2012 | 766 | 1.440 |
Why?
|
| Reactive Oxygen Species | 10 | 2016 | 520 | 1.280 |
Why?
|
| Glycolysis | 7 | 2018 | 171 | 1.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2016 | 180 | 0.980 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2016 | 738 | 0.970 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2025 | 14 | 0.920 |
Why?
|
| Glutathione | 6 | 2016 | 198 | 0.920 |
Why?
|
| Organic Anion Transporters | 1 | 2025 | 23 | 0.920 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2025 | 36 | 0.910 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 56 | 0.890 |
Why?
|
| Isothiocyanates | 3 | 2016 | 12 | 0.890 |
Why?
|
| Antineoplastic Agents | 9 | 2023 | 1812 | 0.870 |
Why?
|
| Neoplasms | 11 | 2023 | 2965 | 0.830 |
Why?
|
| Stromal Cells | 3 | 2013 | 314 | 0.700 |
Why?
|
| Pancreatic Neoplasms | 6 | 2024 | 732 | 0.590 |
Why?
|
| Oxidation-Reduction | 6 | 2014 | 442 | 0.580 |
Why?
|
| Cell Survival | 8 | 2012 | 854 | 0.520 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 19 | 0.500 |
Why?
|
| Chromosome Deletion | 2 | 2016 | 652 | 0.500 |
Why?
|
| Apoptosis | 8 | 2013 | 1860 | 0.400 |
Why?
|
| Cell Communication | 2 | 2012 | 191 | 0.400 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2023 | 825 | 0.390 |
Why?
|
| Brain | 1 | 2025 | 3247 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 611 | 0.370 |
Why?
|
| Mutation | 7 | 2025 | 6200 | 0.370 |
Why?
|
| Cystine | 1 | 2012 | 16 | 0.370 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 108 | 0.350 |
Why?
|
| DNA, Mitochondrial | 4 | 2009 | 241 | 0.350 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 244 | 0.330 |
Why?
|
| Glutamine | 1 | 2011 | 202 | 0.320 |
Why?
|
| Energy Metabolism | 3 | 2018 | 786 | 0.310 |
Why?
|
| Lignans | 1 | 2009 | 7 | 0.300 |
Why?
|
| Pyruvates | 1 | 2009 | 18 | 0.300 |
Why?
|
| Hexokinase | 1 | 2009 | 25 | 0.300 |
Why?
|
| HEK293 Cells | 3 | 2025 | 811 | 0.300 |
Why?
|
| Biphenyl Compounds | 1 | 2009 | 75 | 0.290 |
Why?
|
| Reactive Nitrogen Species | 1 | 2008 | 8 | 0.290 |
Why?
|
| Carcinogens | 2 | 2008 | 129 | 0.290 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 215 | 0.280 |
Why?
|
| Nitrosamines | 1 | 2008 | 15 | 0.280 |
Why?
|
| Leukemia | 1 | 2011 | 375 | 0.280 |
Why?
|
| Cell Respiration | 3 | 2016 | 24 | 0.280 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2024 | 177 | 0.270 |
Why?
|
| Animals | 18 | 2025 | 34460 | 0.270 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 60 | 0.270 |
Why?
|
| Esophagus | 1 | 2009 | 238 | 0.260 |
Why?
|
| Epithelial Cells | 2 | 2009 | 900 | 0.260 |
Why?
|
| Bile Acids and Salts | 1 | 2009 | 259 | 0.250 |
Why?
|
| Chalcones | 1 | 2006 | 5 | 0.250 |
Why?
|
| Boron Compounds | 1 | 2006 | 35 | 0.240 |
Why?
|
| Proteasome Inhibitors | 1 | 2006 | 57 | 0.240 |
Why?
|
| Cell Line, Tumor | 10 | 2018 | 3708 | 0.240 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 175 | 0.240 |
Why?
|
| RNA, Small Interfering | 5 | 2012 | 664 | 0.230 |
Why?
|
| Triiodothyronine | 1 | 2025 | 56 | 0.230 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 85 | 0.230 |
Why?
|
| Thyroxine | 1 | 2025 | 62 | 0.220 |
Why?
|
| Signal Transduction | 5 | 2014 | 4693 | 0.220 |
Why?
|
| Symporters | 1 | 2025 | 75 | 0.220 |
Why?
|
| Humans | 31 | 2025 | 131967 | 0.220 |
Why?
|
| DNA Damage | 2 | 2005 | 527 | 0.220 |
Why?
|
| Biological Transport | 1 | 2025 | 333 | 0.220 |
Why?
|
| Muscular Atrophy | 1 | 2025 | 83 | 0.220 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 392 | 0.220 |
Why?
|
| Blood-Brain Barrier | 1 | 2025 | 151 | 0.210 |
Why?
|
| Muscle Hypotonia | 1 | 2025 | 194 | 0.210 |
Why?
|
| Genomic Instability | 1 | 2005 | 250 | 0.210 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 239 | 0.200 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 79 | 0.200 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2023 | 21 | 0.200 |
Why?
|
| Proteostasis | 1 | 2023 | 36 | 0.200 |
Why?
|
| Endoribonucleases | 1 | 2023 | 86 | 0.190 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2023 | 138 | 0.190 |
Why?
|
| Models, Molecular | 1 | 2025 | 1088 | 0.180 |
Why?
|
| Adenocarcinoma | 3 | 2014 | 1001 | 0.180 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 1545 | 0.170 |
Why?
|
| Mice | 11 | 2024 | 18504 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 2 | 2012 | 130 | 0.170 |
Why?
|
| Enzyme Inhibitors | 1 | 2023 | 566 | 0.160 |
Why?
|
| HL-60 Cells | 2 | 2011 | 32 | 0.160 |
Why?
|
| Immunoblotting | 4 | 2016 | 291 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 2013 | 0.160 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 179 | 0.150 |
Why?
|
| Oncogenes | 2 | 2011 | 164 | 0.140 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 64 | 0.140 |
Why?
|
| Transfection | 3 | 2012 | 960 | 0.140 |
Why?
|
| Flow Cytometry | 3 | 2012 | 772 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 331 | 0.130 |
Why?
|
| Boronic Acids | 3 | 2006 | 49 | 0.130 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 18 | 0.130 |
Why?
|
| Peroxiredoxins | 1 | 2016 | 10 | 0.130 |
Why?
|
| Sirtuin 2 | 1 | 2016 | 13 | 0.130 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2016 | 6 | 0.120 |
Why?
|
| Glutaminase | 1 | 2016 | 18 | 0.120 |
Why?
|
| Mice, Nude | 3 | 2013 | 714 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 489 | 0.120 |
Why?
|
| Cell Line | 2 | 2012 | 2607 | 0.110 |
Why?
|
| Enzyme Activation | 3 | 2012 | 590 | 0.110 |
Why?
|
| Models, Biological | 2 | 2011 | 1396 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 2 | 2005 | 209 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2016 | 364 | 0.110 |
Why?
|
| Deoxycytidine | 1 | 2014 | 82 | 0.110 |
Why?
|
| Genes, ras | 1 | 2014 | 99 | 0.110 |
Why?
|
| Cell Death | 2 | 2018 | 237 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 114 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 231 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 1000 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 989 | 0.090 |
Why?
|
| NADPH Oxidase 1 | 1 | 2012 | 2 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 159 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2014 | 659 | 0.090 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2012 | 28 | 0.090 |
Why?
|
| Tetracycline | 1 | 2012 | 75 | 0.090 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 34 | 0.090 |
Why?
|
| HCT116 Cells | 2 | 2016 | 60 | 0.090 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 83 | 0.090 |
Why?
|
| NADH Dehydrogenase | 1 | 2011 | 5 | 0.090 |
Why?
|
| Vidarabine | 1 | 2012 | 91 | 0.090 |
Why?
|
| Buthionine Sulfoximine | 1 | 2011 | 9 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2012 | 297 | 0.090 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 80 | 0.090 |
Why?
|
| Electron Transport Complex I | 1 | 2011 | 31 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2012 | 1018 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2012 | 240 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 357 | 0.090 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 191 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 140 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 455 | 0.080 |
Why?
|
| Melanoma | 1 | 2018 | 921 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 381 | 0.080 |
Why?
|
| Carcinoma | 1 | 2013 | 283 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 962 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 202 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 2011 | 297 | 0.080 |
Why?
|
| Allyl Compounds | 1 | 2009 | 5 | 0.080 |
Why?
|
| Cyclophilins | 1 | 2009 | 19 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 160 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1790 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2013 | 858 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 455 | 0.070 |
Why?
|
| Phenols | 1 | 2009 | 70 | 0.070 |
Why?
|
| Ubiquitin | 2 | 2006 | 133 | 0.070 |
Why?
|
| Pyrazines | 2 | 2005 | 78 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2011 | 467 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2006 | 80 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3864 | 0.070 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 39 | 0.070 |
Why?
|
| Thioredoxins | 1 | 2008 | 27 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 301 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 240 | 0.070 |
Why?
|
| Bronchi | 1 | 2008 | 102 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 261 | 0.070 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2006 | 26 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 701 | 0.060 |
Why?
|
| DNA Polymerase gamma | 1 | 2005 | 17 | 0.060 |
Why?
|
| eIF-2 Kinase | 1 | 2005 | 35 | 0.060 |
Why?
|
| Lymphoma | 1 | 2009 | 331 | 0.060 |
Why?
|
| Antioxidants | 1 | 2008 | 336 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 318 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 244 | 0.060 |
Why?
|
| Base Sequence | 1 | 2009 | 2783 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 609 | 0.050 |
Why?
|
| Disease Progression | 1 | 2011 | 2226 | 0.050 |
Why?
|
| Piperidines | 1 | 2006 | 231 | 0.050 |
Why?
|
| Homeostasis | 1 | 2008 | 714 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 482 | 0.050 |
Why?
|
| Calcium | 2 | 2005 | 1043 | 0.050 |
Why?
|
| Metalloendopeptidases | 1 | 2024 | 104 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2653 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 126 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 265 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2014 | 230 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 1489 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1610 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 205 | 0.040 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2018 | 8 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2018 | 14 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 91 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 1357 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 705 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2018 | 52 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2018 | 173 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2016 | 810 | 0.030 |
Why?
|
| Comet Assay | 1 | 2016 | 7 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 41 | 0.030 |
Why?
|
| Oxidants | 1 | 2016 | 25 | 0.030 |
Why?
|
| Peroxidase | 1 | 2016 | 64 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1228 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2483 | 0.030 |
Why?
|
| Thapsigargin | 2 | 2005 | 21 | 0.030 |
Why?
|
| Caspase Inhibitors | 2 | 2005 | 32 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 42 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 2123 | 0.030 |
Why?
|
| Bortezomib | 2 | 2005 | 74 | 0.030 |
Why?
|
| Caspases | 2 | 2005 | 157 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 363 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 537 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 4961 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 301 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 313 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 131 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 428 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 579 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 25 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 54 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 495 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 136 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2013 | 68 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2963 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 4762 | 0.020 |
Why?
|
| Chemokines | 1 | 2013 | 127 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2006 | 1572 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 450 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 361 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 217 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 239 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 710 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 417 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 1713 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 1078 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2573 | 0.020 |
Why?
|
| Female | 4 | 2018 | 71316 | 0.020 |
Why?
|
| NAD | 1 | 2006 | 50 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 85 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2005 | 8 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2005 | 5 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2005 | 41 | 0.020 |
Why?
|
| Caspases, Initiator | 1 | 2005 | 5 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2005 | 34 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2005 | 51 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 85 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 254 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 241 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 173 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 345 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 178 | 0.010 |
Why?
|
| Pancreas | 1 | 2005 | 218 | 0.010 |
Why?
|
| Cisplatin | 1 | 2005 | 286 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 358 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 1020 | 0.010 |
Why?
|
| Cyclin A | 1 | 2002 | 17 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 580 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2002 | 25 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2002 | 43 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 139 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 236 | 0.010 |
Why?
|
| ARNTL Transcription Factors | 1 | 2002 | 46 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2002 | 102 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2002 | 109 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6922 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2002 | 195 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 731 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 598 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 1219 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 602 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 10108 | 0.010 |
Why?
|
| Male | 2 | 2018 | 65357 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 1131 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 21279 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 2578 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 2442 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 4531 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 28911 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 6285 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 31734 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 3425 | 0.010 |
Why?
|